NanoEntek, Inc.

KOSDAQ:A039860 Rapport sur les actions

Capitalisation boursière : ₩128.4b

NanoEntek Résultats passés

Passé contrôle des critères 0/6

NanoEntek's earnings have been declining at an average annual rate of -33.2%, while the Life Sciences industry saw earnings growing at 31.2% annually. Revenues have been growing at an average rate of 1.9% per year.

Informations clés

-33.2%

Taux de croissance des bénéfices

-33.5%

Taux de croissance du BPA

Life Sciences Croissance de l'industrie53.7%
Taux de croissance des recettes1.9%
Rendement des fonds propres-0.7%
Marge nette-1.7%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Recent updates

Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%

Oct 10
Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%

NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

Aug 06
NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Mar 21
NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 14
Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Jan 26
If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

Jan 04
Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 14
NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Ventilation des recettes et des dépenses

Comment NanoEntek gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

KOSDAQ:A039860 Recettes, dépenses et bénéfices (KRW Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 2427,804-4738,8583,689
31 Mar 2427,060-2,8369,5983,689
31 Dec 2326,837-3,6789,7943,689
30 Sep 2326,656-5,0439,8673,550
30 Jun 2329,016-1,19910,0383,550
31 Mar 2331,5742,5058,9273,550
31 Dec 2235,2014,6658,0683,550
30 Sep 2237,7117,5058,3872,968
30 Jun 2236,0355,9617,9142,968
31 Mar 2234,5026,0287,5522,968
31 Dec 2135,7847,3218,0212,968
30 Sep 2136,1076,9448,9792,455
30 Jun 2135,0766,2358,2442,455
31 Mar 2134,5134,4637,8712,455
31 Dec 2029,4432,7377,1472,455
30 Sep 2026,3193,8879,155386
30 Jun 2026,9875,5658,486825
31 Mar 2028,1027,1827,5371,182
31 Dec 1926,2565,7506,7441,519
30 Sep 1925,3884,4076,3721,452
30 Jun 1924,8953,5006,1511,276
31 Mar 1923,8512,8435,9371,222
31 Dec 1825,7973,3085,6741,241
30 Sep 1825,7547185,3371,340
30 Jun 1825,4741385,6281,463
31 Mar 1824,895-6585,8771,496
31 Dec 1723,810-2,0725,5651,376
30 Sep 1723,080-7,3857,7561,591
30 Jun 1722,454-9,6218,0151,712
31 Mar 1722,289-12,9579,4101,893
31 Dec 1622,206-14,79910,6282,111
30 Sep 1624,877-11,14610,7882,020
30 Jun 1624,730-10,67911,2141,734
31 Mar 1625,706-8,77710,1081,535
31 Dec 1524,839-7,28210,0191,332
30 Sep 1523,548-3,1457,902980
30 Jun 1522,069-2,7367,011942
31 Mar 1519,664-2,7456,633859
31 Dec 1419,499-2,4645,874740
30 Sep 1419,097-2,1175,291495
30 Jun 1419,529-1,7524,697388
31 Mar 1419,253-1,0354,471329
31 Dec 1319,084-1,2374,278438

Des revenus de qualité: A039860 is currently unprofitable.

Augmentation de la marge bénéficiaire: A039860 is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: A039860 is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.

Accélération de la croissance: Unable to compare A039860's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: A039860 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (18%).


Rendement des fonds propres

ROE élevé: A039860 has a negative Return on Equity (-0.66%), as it is currently unprofitable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé